Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes

Atherosclerosis

Volumn 220, Issue 2, 2012, Pages 437-442

  Katakami, Naoto ^a   Kaneto, Hideaki ^a   Matsuoka, Taka aki ^a   Takahara, Mitsuyoshi ^a   Maeda, Norikazu ^a   Shimizu, Ikki ^b   Ohno, Keizo ^c   Osonoi, Takeshi ^d   Kawai, Koichi ^e   Ishibashi, Fukashi ^f   Imamura, Kenichi ^g   Kashiwagi, Atsunori ^h   Kawamori, Ryuzo ⁱ   Matsuhisa, Munehide ^j   Funahashi, Tohru ^a   Yamasaki, Yoshimitsu ^k   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Prefectural Ehime Imabari Hospital   (Japan)

^d Naka Memorial Clinic   (Japan)

^e Kawai Clinic   (Japan)

^f Ishibashi Clinic   (Japan)

^g Imamura Clinic   (Japan)

^h SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁱ JUNTENDO UNIVERSITY   (Japan)

^j UNIVERSITY OF TOKUSHIMA   (Japan)

^k OSAKA UNIVERSITY   (Japan)

more..

Author keywords

Adiponectin; Cardiovascular disease; Diabetes; Obesity; Polymorphism

Indexed keywords

ADIPONECTIN;

ADULT; ALLELE; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADIPONECTIN; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; CEREBRAL INFARCTION; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84855934090     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.11.010     Document Type: Article

References (27)

1. Fruebis J., Tsao T.S., Javorschi S., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001, 98:2005-2010.
2. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMPactivated protein kinase. Nat Med 2002, 8:1288-1295.
3. Stefan N., Stumvoll M. Adiponectin: its role in metabolism and beyond. Horm Metab Res 2002, 34:469-474.
4. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002, 8:731-737.
5. Arita Y., Kihara S., Ouchi N., et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002, 105:2893-2898.
6. Ouchi N., Ohishi M., Kihara S., et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003, 42:231-234.
7. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20:1595-1599.
8. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-58.
9. Spranger J., Kroke A., Möhlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361:226-228.
10. Daimon M., Oizumi T., Saito T., et al. Funagata Study. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 2003, 26:2015-2020.
11. Krakoff J., Funahashi T., Stehouwer C.D., et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003, 26:1745-1751.
12. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89.
13. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
14. Chen M.P., Tsai J.C., Chung F.M., et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 2005, 25:821-826.
15. Hara K., Boutin P., Mori Y., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536-540.
16. Bacci S., Menzaghi C., Ercolino T., et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004, 27:2015-2020.
17. Lacquemant C., Froguel P., Lobbens S., Izzo P., Dina C., Ruiz J. The Adiponectin gene SNP+45 is associated with coronary artery disease in type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 2004, 21:776-781.
18. Jang Y., Lee J.H., Chae J.S., et al. Association of the 276G→T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 2005, 82:760-767.
19. Qi L., Li T., Rimm E., et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005, 54:1607-1610.
20. Filippi E., Sentinelli F., Romeo S., et al. The adiponectin gene SNP+ 276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age
21. Jung C.H., Rhee E.J., Kim S.Y., et al. Associations between two single nucleotide polymorphisms of Adiponectin gene and coronary artery diseases. Endocr J 2006, 53:671-677.
22. Gable D.R., Matin J., Whittall R., et al. HIFMECH investigators, Common Adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Ann Hum Genet 2007, 71:453-466.
23. Chiodini B.D., Specchia C., Gori F., et al. GISSI Prevenzione Investigators, Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther Adv Cardiovasc Dis 2010, 4:223-230.
24. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347:1916-1923.
25. Yu S.Y., Ryu H.K., Park H.J., Choi Y.J., Huh K.B., Kim W.Y. Adiponectin gene SNP 276G→T, nutrient intakes, and cardiovascular disease risk in Korean type 2 DM patients. Nutr Res Pract 2007, 1:363-370.
26. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
27. Asayama K., Hayashibe H., Dobashi K., et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003, 11:1072-1079.